A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma
Head & Neck2005Vol. 27(9), pp. 771–784
Citations Over TimeTop 10% of 2005 papers
Colleen Druzgal, Zhong Chen, Ning T. Yeh, Giovana R. Thomas, Frank G. Ondrey, Dianne C. Duffey, Ronald J. Vilela, Kevin Ende, Linda McCullagh, Susan F. Rudy, Christine Muir, Laurie L. Herscher, John C. Morris, Paul S. Albert, Carter Van Waes
Abstract
Longitudinal changes in serum HGF, IL-6, IL-8, and VEGF were detected with treatment response, relapse, or complications in individual patients and were associated with survival, with HGF showing the strongest relationship with survival. HGF, IL-6, IL-8, and VEGF merit investigation as markers of response, survival, and recurrence in larger prospective studies.
Related Papers
- → The vasohibin family: a novel family for angiogenesis regulation(2012)113 cited
- → The vasohibin family: Novel regulators of angiogenesis(2012)27 cited
- → Differential Mitogenic Effects of Single Chain Hepatocyte Growth Factor (HGF)/Scatter Factor and HGF/NK1 following Cleavage by Factor Xa(2002)19 cited
- [Hepatocyte growth factor (HGF) and its therapeutic applications].(2005)
- → A PlGF-1 Derived Peptide Inhibits Angiogenesis via HIF-1β/VEGF Pathway(2016)